Scholars Central

Conference abstract

Mesenchymal stem/stromal cells (MSCs) in regenerative medicine

Authors: Joni H.Ylostalo

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Recently, stem cells have become more and more popular in regenerative medicine approaches. In a search for a safe and therapeutically beneficial stem cell, many biomedical researchers have turned into using mesenchymal stem/stromal cells (MSCs) in their regenerative medicine endeavors. The pioneering work of Friedenstein in the 1960s with clonal, plastic adherent bone marrow-derived non- hematopoietic cells laid the ground for the introduction of MSCs in the 1990s. Since, MSCs and MSC- like cells have been isolated from various tissue sources and the multipotential differentiation capability has been demonstrated extensively. The minimum criteria for MSCs include plastic adherence, in vitro differentiation into adipogenic, chondrogenic and osteogenic lineages, absence of hematopoietic surface markers, and expression of C105, CD90, and CD73. MSCs have been shown to aid in repair of injured tissues through multiple mechanisms including differentiation, transfer of mitochondria or vesicles, stimulation of endogenous stem cells, suppression of apoptosis, and immunomodulation. Recently, the focus of the MSC therapeutics has sifted from a transdifferentiation approaches into a paracrine effects of MSCs. In particular, immunosuppressive properties of MSCs have attracted much research and great discoveries have been made in identifying therapeutically beneficial molecules secreted by MSCs. MSCs can act on both innate and adaptive immune systems by suppressing T cells, suppressing dendritic cell maturation, reducing B cell activation and proliferation, inhibiting proliferation and cytotoxicity of NK cell, and promoting the generation of regulatory T cells. Hence, MSCs have shown promise in both pre- clinical and clinical trials to treat GVHD and myocardial infarction, and support transplantation. Still, much remains unresolved about basic MSC biology and the mechanisms of MSC therapeutics.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Stem Cell Research & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Stem Cell Research & Therapy
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Joni H.Ylostalo”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels